
Obalon Therapeutics, Inc. Retained Earnings 2011-2026 | OBLN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -185 M | -172 M | -149 M | -111 M | -76.6 M | -56.1 M | -40.6 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -40.6 M | -185 M | -113 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.48 B | $ 184.69 | 2.23 % | $ 13.8 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
-307 M | $ 34.46 | 2.96 % | $ 1.59 B | ||
|
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.77 | 3.65 % | $ 1.73 B | ||
|
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | ||
|
Bio-Rad Laboratories
BIO
|
7.42 B | $ 292.23 | 1.41 % | $ 8.24 B | ||
|
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.37 | 1.35 % | $ 126 M | ||
|
Bruker Corporation
BRKR
|
2.41 B | $ 39.9 | 2.18 % | $ 5.94 K | ||
|
Boston Scientific Corporation
BSX
|
5.57 B | $ 63.82 | 1.01 % | $ 94.5 B | ||
|
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.59 | 0.67 % | $ 36.7 M | ||
|
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-217 M | $ 10.38 | 3.7 % | $ 294 M | ||
|
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
21.2 M | $ 25.21 | 1.47 % | $ 213 M | ||
|
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | ||
|
Helius Medical Technologies
HSDT
|
-160 M | $ 1.98 | -2.46 % | $ 1.2 M | ||
|
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | ||
|
Inogen
INGN
|
-176 M | $ 6.34 | -1.71 % | $ 169 M | ||
|
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.03 | - | $ 17.4 M | ||
|
Globus Medical
GMED
|
1.39 B | $ 94.94 | 2.11 % | $ 12.8 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.86 | 5.37 % | $ 419 M | ||
|
Butterfly Network
BFLY
|
-802 M | $ 4.44 | 3.74 % | $ 940 M | ||
|
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | ||
|
LENSAR
LNSR
|
-178 M | $ 6.04 | 2.03 % | $ 72.2 M | ||
|
Delcath Systems
DCTH
|
-529 M | $ 10.88 | 4.11 % | $ 390 M | ||
|
Inspire Medical Systems
INSP
|
-146 M | $ 56.83 | 3.48 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
589 M | $ 39.73 | 3.3 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
-1.15 B | $ 64.99 | 0.63 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
994 M | $ 88.63 | 1.03 % | $ 3.08 B | ||
|
FONAR Corporation
FONR
|
-33.6 M | $ 18.76 | 0.27 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 78.2 | 0.1 % | $ 45.7 B | ||
|
Myomo
MYO
|
-119 M | $ 0.79 | 8.49 % | $ 33.1 M |